Amgen and Novartis Partnership for Alzheimer’s Disease
Amgen and Novartis have announced a partnership for the development of BACE inhibitor drugs, including CNP520, which is being used in the Alzheimer’s Prevention Initiative (API) APOE4 trial. This significant investment demonstrates the esteem in with which the API...
Read moreArizona State University and Banner Health launch major effort to fight neurodegenerative diseases
Tempe, Arizona (June 10, 2015) – Arizona State University and Banner Health today announced a new research alliance to advance the scientific study, treatment and prevention of Alzheimer’s, Parkinson’s and other neurodegenerative diseases. The partnership between Arizona State University...
Read moreBanner Alzheimer’s Institute receives $10 million in new research funding
Banner Alzheimer’s Institute has received $10 million in new research funding through the Alzheimer’s Association, in partnership with the GHR Foundation and Fidelity Biosciences Research Initiative. The new funding is in support of a groundbreaking Alzheimer’s disease prevention trial...
Read moreArizona Alzheimer’s Consortium Working Together To End Alzheimer’s Disease
Arizona Alzheimer’s Consortium researchers, leaders from the Consortium’s member institutions, and Governor Doug Ducey discuss how they will make a real difference in the fight against Alzheimer’s disease. . .
Read more“Solving the Alzheimer’s Mystery” in the Arizona Republic
The Arizona Republic recently featured a two-part series titled “Solving the Alzheimer’s Mystery.” Click here to read the full series on azcentral.com. IN COLOMBIA, WHERE FAMILIES WITH A GENETIC MUTATION ARE DOOMED TO FACE ALZHEIMER’S, A $100 MILLION DRUG TRIAL...
Read moreAlzheimer’s Drug Discovery Foundation’s 9th Annual Conference in San Diego March 2015
AD researchers may be interested to attend the Alzheimer’s Drug Discovery Foundation’s 9th annual conference in San Diego on March 1-3, 2015: Drug Discovery for Neurodegeneration Conference: An Intensive Course on Translating Research into Drugs The Alzheimer’s Drug Discovery...
Read more“Understanding Alzheimer’s” Featured In Living Well A-Z November 2014
The November 2014 edition of Living Well A-Z in the Arizona Republic features an article highlighting several Arizona Alzheimer’s Consortium members. Click here to read the November 2014 Living Well A-Z (article starts on page 6). . .
Read moreTGen’s Mindcrowd Featured on STEM Journals on Sunday, September 21st
TGen’s online cognitive study MindCrowd will be featured on an upcoming episode of STEM Journals on Sunday, September 21st at 7pm on Cox 7 or 1007. MindCrowd is the first research project of its kind. Researchers hope that a million people worldwide will spend...
Read moreGenentech Neuroscientist to Speak at ASU About Advances in Alzheimer’s Drug Development
New discoveries that may increase the effectiveness of Alzheimer’s treatments will be the topic at a Discovery Series presentation at the Biodesign Institute at ASU on Wednesday, Sept. 10 at 10 a.m. Genentech neuroscientist Ryan Watts, PhD, will discuss...
Read moreNew Funding Opportunity Alert — Department of Defense
The Department of Defense Peer Reviewed Alzheimer Research Program has new information available about research funding opportunities and its program goals for the future. This unique research program provides funding to address the long-term consequences of traumatic brain injury as they pertain to...
Read more